Matthieu Atger
Healing Connections
- Psilocybin and the Reconstruction of the Mind
ISBN: 978-3-758-48357-8
56 Seiten | € 19.99
Buch [Taschenbuch]
Erscheinungsdatum:
05.03.2024
Ratgeber
Matthieu Atger
Healing Connections
Psilocybin and the Reconstruction of the Mind
This literature review examines the rising global crisis of mental health disorders, focusing on major depressive disorder (MDD), a condition affecting millions worldwide. It critiques the limitations of conventional treatments like SSRIs, which, despite their efficacy for some, often require weeks to take effect and are associated with significant side effects and a high rate of non-response.
In this context, psilocybin - a classical psychedelic - emerges as a promising alternative, offering potential for more effective, safer, and faster-acting treatment. The review covers the historical context of psychedelic research, the FDA's recognition of psilocybin as a "breakthrough therapy," and further examines clinical evidence for psilocybin, its mechanisms of action, and its impact on neuronal networks in treating major depressive disorder.
By comparing psilocybin's rapid and long-lasting therapeutic benefits to those of traditional antidepressants, the review advocates for a paradigm shift in mental health treatment towards embracing psychedelics' potential. However, it also discusses obstacles to psilocybin's research and clinical use, such as its Schedule I classification and the need for a comprehensive therapeutic framework, advocating for rescheduling and the development of an evidence-based approach to harness its potential.
In this context, psilocybin - a classical psychedelic - emerges as a promising alternative, offering potential for more effective, safer, and faster-acting treatment. The review covers the historical context of psychedelic research, the FDA's recognition of psilocybin as a "breakthrough therapy," and further examines clinical evidence for psilocybin, its mechanisms of action, and its impact on neuronal networks in treating major depressive disorder.
By comparing psilocybin's rapid and long-lasting therapeutic benefits to those of traditional antidepressants, the review advocates for a paradigm shift in mental health treatment towards embracing psychedelics' potential. However, it also discusses obstacles to psilocybin's research and clinical use, such as its Schedule I classification and the need for a comprehensive therapeutic framework, advocating for rescheduling and the development of an evidence-based approach to harness its potential.
Unterstütze den lokalen Buchhandel
Besuche doch eine der folgenden Buchhandlungen in deiner Nähe
Bestelle dieses Buch im Internet
Veröffentlichung: | 05.03.2024 |
Höhe/Breite/Gewicht | H 29,7 cm / B 21 cm / 192 g |
Seiten | 56 |
Art des Mediums | Buch [Taschenbuch] |
Preis DE | EUR 19.99 |
Preis AT | EUR 19.99 |
Auflage | 1. Auflage |
ISBN-13 | 978-3-758-48357-8 |
ISBN-10 | 3758483573 |
Über den Autor
Matthieu Atger is an enthusiastic medical student dedicated to pushing the boundaries of our comprehension of mental health disorders and investigating innovative therapeutic approaches. With a profound fascination for psychiatry and neuroscience, Atger blends scholarly rigor with empathetic inquiry in his studies.Diesen Artikel teilen
0 Kommentar zu diesem Buch
.... weitere Publikationen von epubli
Leserunde